Yu Jia-Li, Liu Qing-Yang, Yang Bo, Sun Yi-Fan, Wang Ya-Ju, Jiang Jian, Wang Bo, Cheng Yang, Wang Qiu-Bo
Laboratory of Pathogen Infection and Immunity, Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China.
Department of Clinical Laboratory, Wuxi 9th Affiliated Hospital of Soochow University (Wuxi 9th People's Hospital), Wuxi 214000, China.
Pathogens. 2022 May 7;11(5):550. doi: 10.3390/pathogens11050550.
, mainly distributed in tropical and subtropical regions of the world, has received widespread attention owing to its severity. As a novel protein, surface-related antigen (PfSRA) has the structural and functional characteristics to be considered as a malaria vaccine candidate; however, limited information is available on its immunogenicity. Here, we expressed three fragments of recombinant PfSRA in an system and further analyzed its immunogenicity. The results showed that rPfSRA-immunized mice produced specific antibodies with high endpoint titers (1:10,000 to 1:5,120,000) and affinity antibodies (i.e., rPfSRA-F1a (97.70%), rPfSRA-F2a (69.62%), and rPfSRA-F3a (91.87%)). In addition, the sera of immunized mice recognized both the native PfSRA and recombinant PfSRA, the rPfSRA antibodies inhibited the invasion of into the erythrocytes, and they were dose-dependent in vitro. This study confirmed PfSRA could be immunogenic, especially the F1a at the conserved region N-terminal and provided further support for it as a vaccine candidate against .
主要分布于世界热带和亚热带地区,因其严重性而受到广泛关注。作为一种新型蛋白质,表面相关抗原(PfSRA)具有被视为疟疾疫苗候选物的结构和功能特征;然而,关于其免疫原性的信息有限。在此,我们在一个系统中表达了重组PfSRA的三个片段,并进一步分析了其免疫原性。结果显示,用rPfSRA免疫的小鼠产生了具有高终点滴度(1:10,000至1:5,120,000)的特异性抗体和亲和抗体(即rPfSRA-F1a(97.70%)、rPfSRA-F2a(69.62%)和rPfSRA-F3a(91.87%))。此外,免疫小鼠的血清识别天然PfSRA和重组PfSRA,rPfSRA抗体在体外抑制疟原虫侵入红细胞,且呈剂量依赖性。本研究证实PfSRA具有免疫原性,尤其是保守区域N端的F1a,并为其作为抗疟疫苗候选物提供了进一步支持。